SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001520138-16-000738
Filing Date
2016-02-16
Accepted
2016-02-16 17:03:05
Documents
32
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q FOR PERIOD ENDED DECEMBER 31, 2015 nnab-20151231_10q.htm 10-Q 202317
2 EXHIBIT 31.1 nnab-20151231_10qex31z1.htm EX-31.1 12133
3 EXHIBIT 32.1 nnab-20151231_10qex32z1.htm EX-32.1 5844
  Complete submission text file 0001520138-16-000738.txt   994714

Data Files

Seq Description Document Type Size
4 XBRL LABEL FILE nnab-20151231_lab.xml EX-101.LAB 94352
5 XBRL PRESENTATION FILE nnab-20151231_pre.xml EX-101.PRE 67993
6 XBRL SCHEMA FILE nnab-20151231.xsd EX-101.SCH 11936
7 XBRL INSTANCE FILE nnab-20151231.xml EX-101.INS 120394
8 XBRL CALCULATION FILE nnab-20151231_cal.xml EX-101.CAL 15145
9 XBRL DEFINITION FILE nnab-20151231_def.xml EX-101.DEF 14131
Mailing Address 100 CUMMINGS CENTER, SUITE 247-C BEVERLY MA 01915
Business Address 100 CUMMINGS CENTER, SUITE 247-C BEVERLY MA 01915 3055154118
NANOANTIBIOTICS, INC. (Filer) CIK: 0001580149 (see all company filings)

IRS No.: 462510769 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-55292 | Film No.: 161429993
SIC: 2834 Pharmaceutical Preparations